Medicare Prescription Plans May Take Longer to Cover New Generic Drugs
Pharmacists can help advocate for availability and coverage.
What Pharmacists Should Know About the FDA’s DCAP for Generic Drug Access
Removing patient barriers to generic drugs.
Generic Drug Pricing Trends
Savings totaled $293 billion in 2018.
Generic Drugs 101: What Pharmacists Need to Know
Abbreviated New Drug Applications, state laws, and more.
What Are Authorized Generics?
October 4, 2019
Authorized generics have been gaining popularity with pharmaceutical manufacturers, but just how do they impact pharmacies?
Biosimilars: Some Call for ‘Cautious Optimism’
October 1, 2019
Biosimilars may need more time to devleop in the market.
Generics of Older Drugs Could Have Saved Medicare Billions, Study Says
September 30, 2019
Racemic substitutions for single-enantiomer drugs offer new opportunities for savings.
Generics and Biosimilars Facing Formulary Difficulties
September 11, 2019
New changes are making it more difficult for generics and biosimilars to compete on formularies.
Decitabine and Fosaprepitant Generics Approved by FDA
September 6, 2019
First generic specialty injections approved for Novadoz Pharmaceuticals.
Generic VESIcare Tablets to Launch in U.S.
May 21, 2019
Update: now available from three manufacturers.
